Mirador Therapeutics

Develops precision medicines for immune-mediated and immuno-fibrotic diseases through a multi-asset clinical pipeline.

View on the globe

$250MEquity raised in 2025–20262025 — · 2026 $250M · 1 equity round
$250MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed

Rounds over time log-scaled amounts

Funding history: 1 round from 12 Jan 2026 to 12 Jan 2026, $250M equity disclosed. Earlier rounds exist but are not sourced.12 Jan 2026: Series B, $250M$10M$30M$100M$300M$1BEarlier rounds exist but are not sourced yet← earlier rounds not sourcedest. 2024Q3Q42026Q2Q3Q4Equity round12 Jan 2026 · Series B · $250MSeries B · $250M
Funding history: 1 round from 12 Jan 2026 to 12 Jan 2026, $250M equity disclosed. Earlier rounds exist but are not sourced.12 Jan 2026: Series B, $250M$10M$30M$100M$300M$1BEarlier rounds exist but are not sourced yetearlier rounds not sourced’24Q3Q42026Q2Q3Q4Equity round12 Jan 2026 · Series B · $250M$250M

Funding history 1 round · 2 sources

Earlier rounds not yet sourced. Mirador Therapeutics was founded in 2024 and raised before 12 Jan 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Series B
    Amount$250M
    Post-money—
    ✓ Confirmed
    Also
    T. Rowe Price, Fidelity, ARCH Venture Partners, Point72, Blue Owl, Venrock
    Note
    No lead named. New investors include T. Rowe Price, Adage Capital and Fidelity-managed funds; returning Series A investors include ARCH, OrbiMed, Fairmount, Point72, Farallon, Boxer, TCGX, Invus, Venrock Healthcare and others. Total raised more than $650M since the March 2024 launch; the Series A is not sourced here, and the release text refers to the Series B as Q3 2025.
    Sources
  2. Earlier rounds not yet sourced

Investors 6

  • ARCH Venture Partners
  • Blue Owl
  • Fidelity
  • Point72
  • T. Rowe Price
  • Venrock

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Also in the San Diego hub see on the globe

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Mirador Therapeutics and its logo are trademarks of their owners, used here for identification only.